phospholamban ; Mus musculus






83 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1346732 Immunohemopoietic effects of dietary nucleotide restriction in mice. Transplantation 1992 Feb 1
2 1363474 Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids. Immunopharmacol Immunotoxicol 1992 1
3 1688560 The Mel 14 antibody binds to the lectin domain of the murine peripheral lymph node homing receptor. J Cell Biol 1990 Jan 4
4 3110270 Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol 1987 Jul 15 1
5 3262595 Immunopathological signs in mice treated with mercury compounds--I. Identification by the popliteal lymph node assay of responder and nonresponder strains. Int J Immunopharmacol 1988 5
6 7612820 Molecular dynamics in mouse atrial tumor sarcoplasmic reticulum. Biophys J 1995 May 1
7 8760070 Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+. Am J Physiol 1996 Jul 3
8 8764561 T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin Immunol Immunopathol 1996 Aug 2
9 9118481 Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. Circ Res 1997 Apr 4
10 9252436 Phospholamban ablation enhances relaxation in the murine soleus. Am J Physiol 1997 Jul 1
11 9314829 Monomeric phospholamban overexpression in transgenic mouse hearts. Circ Res 1997 Oct 3
12 9435620 Regulatory effects of phospholamban on cardiac function in intact mice. Am J Physiol 1997 Dec 8
13 9575939 Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol 1998 Apr 1
14 9922946 Evaluation of allergenic potential of low-molecular compounds by mouse popliteal lymph node assay. J Toxicol Sci 1998 Dec 3
15 10024311 Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice. Circ Res 1999 Feb 19 1
16 10484417 [Ca2+]i homeostasis and cyclic nucleotide relaxation in aorta of phospholamban-deficient mice. Am J Physiol 1999 Sep 3
17 10603985 Pharmacology of the cardiac sarcoplasmic reticulum calcium ATPase-phospholamban interaction. Ann N Y Acad Sci 1998 Sep 16 3
18 10809743 The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J Biol Chem 2000 May 19 2
19 10845191 Differentiation of responses to allergenic and irritant compounds in mouse popliteal lymph node assay. J Toxicol Sci 2000 May 1
20 11087739 Phospholamban decreases the energetic efficiency of the sarcoplasmic reticulum Ca pump. J Biol Chem 2001 Mar 9 2
21 11502581 Role of phospholamban in the modulation of arterial Ca(2+) sparks and Ca(2+)-activated K(+) channels by cAMP. Am J Physiol Cell Physiol 2001 Sep 2
22 11559781 Phospholamban regulation of bladder contractility: evidence from gene-altered mouse models. J Physiol 2001 Sep 15 3
23 11854448 Reconstitution of the cytoplasmic interaction between phospholamban and Ca(2+)-ATPase of cardiac sarcoplasmic reticulum. Mol Pharmacol 2002 Mar 2
24 11992736 Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA. Toxicol Lett 2002 May 28 12
25 12781630 Oxazolone and diclofenac-induced popliteal lymph node assay reactions are attenuated in mice orally pretreated with the respective compound: potential role for the induction of regulatory mechanisms following enteric administration. Toxicol Appl Pharmacol 2003 Jun 1 3
26 14985072 Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts. Cardiovasc Res 2004 Mar 1 3
27 15059971 Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodeling. FASEB J 2004 Jun 1
28 15276030 Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. J Mol Cell Cardiol 2004 Aug 6
29 15358683 Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling. FASEB J 2004 Nov 1
30 16436691 Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. Antimicrob Agents Chemother 2006 Feb 1
31 16461894 Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc Natl Acad Sci U S A 2006 Feb 14 2
32 16516179 Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart. Cardiovasc Res 2006 May 1 3
33 16849635 Transcriptional response to persistent beta2-adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility. Physiol Genomics 2006 Oct 11 1
34 16861697 Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol 2006 Dec 2
35 17950750 Effects on recovery during acidosis in cardiac myocytes overexpressing CaMKII. J Mol Cell Cardiol 2007 Dec 1
36 18007024 Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 2008 Feb 1 1
37 18045856 Phospholamban knockout increases CaM kinase II activity and intracellular Ca2+ wave activity and alters contractile responses of murine gastric antrum. Am J Physiol Cell Physiol 2008 Feb 4
38 18064719 AAV-mediated knockdown of phospholamban leads to improved contractility and calcium handling in cardiomyocytes. J Gene Med 2008 Feb 2
39 18400986 Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. Am J Physiol Cell Physiol 2008 Jun 3
40 19696029 Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem 2009 Oct 9 2
41 19959778 Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice. Circ Res 2010 Feb 5 1
42 20392835 Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications. Endocrinology 2010 Jun 5
43 20833651 Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc Res 2011 Feb 1 1
44 20942811 cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol 2011 Jan 2
45 21840315 Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein. J Mol Cell Cardiol 2011 Nov 1
46 21903937 Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ current. Circ Res 2011 Oct 14 2
47 21945464 Sub-cellular targeting of constitutive NOS in health and disease. J Mol Cell Cardiol 2012 Feb 1
48 22484619 Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes. J Mol Cell Cardiol 2012 Jun 2
49 23624088 Myofilament Ca2+ desensitization mediates positive lusitropic effect of neuronal nitric oxide synthase in left ventricular myocytes from murine hypertensive heart. J Mol Cell Cardiol 2013 Jul 1
50 23658728 Integrative effect of carvedilol and aerobic exercise training therapies on improving cardiac contractility and remodeling in heart failure mice. PLoS One 2013 1